Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]
When most people with type 1 diabetes (T1D) think about hormones, insulin is usually the first one that comes to mind—people with T1D use it daily to survive. But it takes more than just insulin to regulate blood-glucose levels. Hormones act as chemical messengers in the human body—they are released by a cell, organ, or […]
JDRF-funded researchers have developed a formulation of liquid glucagon that remains stable and viable for long periods of time and thus may be usable in standard diabetes pumps. The research represents advancement toward the routine delivery of glucagon for people with T1D and may also facilitate the development of bihormonal closed-loop artificial pancreas systems.
by Talley Henning Brown I know 15 teachers, 29 musicians, and five lawyers. I know 34 “cat people” and 43 “dog people.” I know eight marathon runners and four yoga instructors. I even know someone who knows the president of the United States. I know, in short, a lot of people—and a lot of things […]
By Darren Bolton Chalk it up to a “life lesson” that was well-learned and safely resolved. Sometimes you get thrown an unexpected curveball, just when you think you have everything under control. Here’s my story. When I was first asked to write this article about managing an emergency low-blood-sugar episode for Countdown, I was not […]
These developments represent a giant step forward on the path to achieving an artificial pancreas, a fully automated system that can dispense insulin to patients based on real-time changes in blood sugar levels. Even the earliest systems could bring dramatic changes in the quality of life for people with type 1 diabetes.